| Name | Title | Contact Details |
|---|
iHealth is dedicated to helping people lead healthier lives. Our goal is to make it as easy as possible for individuals of all ages to take a more active role in managing their health. We do this by designing and manufacturing innovative, consumer-friendly, mobile personal healthcare products that connect to the cloud. Our products are easy-to-use, making it simple for consumers to accurately measure, track and share a full range of health vitals. By automatically connecting the data through the cloud, consumers are able to see a more comprehensive view of their vitals and easily share information with healthcare professionals or loved ones. Our award-winning line of products include blood pressure monitors, blood glucose monitors, body analysis scales, pulse oximeters and activity and sleep trackers. All of our products sync directly with a free mobile app that makes monitoring, viewing, storing and sharing of health vitals simple and comprehensive.
Midway Dental Supply Inc is a Lakeville, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Healthline Med is a Baldwin Park, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
sound advice audiology inc is a Portland, ME-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
BioSig Technologies, Inc. (NASDAQ: BSGM) is a medical device company that is developing a proprietary biomedical signal processing technology platform to address an unmet technology need in the rapidly growing $4.6+ billion electrophysiology (EP) marketplace. Led by a proven management team, world-class Board of Directors and Scientific Advisory Board, Los Angeles-based BioSig Technologies is preparing to commercialize its PURE EP™ System. The PURE EP™System is a surface electrocardiogram (ECG) and intracardiac multichannel recording and analysis system designed to assist electrophysiologists in making crucial clinical decisions in real-time by acquiring and displaying high-fidelity cardiac signal recordings even at undetectable levels (until now) with high accuracy to help identify appropriate catheter ablation targets - areas of tissue to destroy that create a heart rhythm disturbance (arrhythmia). BioSig aims to deliver technology to improve upon catheter ablation treatments for the prevalent and potentially deadly arrhythmias, Atrial Fibrillation and Ventricular Tachycardia. PURE EP™ System is an innovative platform, offering potential benefits over current technologies including increased accuracy, reduced noise and interference, clinical information previously not available and potential elimination of the need for repeat procedures. BioSig has partnered with Minnetronix on technology development and has received FDA 510(k) clearance for the PURE EP™ System in August 2018. BioSig Technologies, Inc. is a Nasdaq company: NASDAQ:BSGM.